Skip to main content
. 2017 May 25;2017(5):CD006109. doi: 10.1002/14651858.CD006109.pub3
D. Risk of bias assessment
    YES NO Unclear
Study size Was a power calculation performed and adhered?      
Selection bias Was the allocation sequence adequately generated?      
Was the patient allocation concealment adequate?      
Detection bias Was the length of follow‐up long enough to detect stated outcomes?      
Was the investigator (performer of hormone administration) blinded?      
Was the outcome assessor blinded?      
Were the participants blinded?      
Attrition bias Was loss to follow‐up accounted for?      
Was an intention‐to‐treat analysis performed?      
Reporting bias Where there any suggestions of selective report of outcome?      
Source of funding Is the source of funding stated?      
Remarks: